Michael Morrissey
Chief Executive Officer bei EXELIXIS, INC.
Vermögen: 59 Mio $ am 31.03.2024
Profil
Derzeit bekleidet Michael M. Morrissey die Position des President, Chief Executive Officer & Director bei Exelixis, Inc. Dr. Morrissey ist außerdem Mitglied des Vorstands von XWPharma Ltd. In seiner früheren Karriere war Dr. Morrissey als Senior Scientist bei Ciba-Geigy Corp. und als Vice President-Discovery Research bei Berlex Biosciences tätig. Michael M. Morrissey erhielt einen Doktortitel von der Harvard University und einen Bachelor-Abschluss von der University of Wisconsin.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
EXELIXIS, INC.
0,82% | 23.02.2024 | 2 492 969 ( 0,82% ) | 59 Mio $ | 31.03.2024 |
| 18.03.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Michael Morrissey
| Unternehmen | Position | Beginn |
|---|---|---|
| EXELIXIS, INC. | Chief Executive Officer | 22.07.2010 |
| VERA THERAPEUTICS, INC. | Chairman | 24.05.2022 |
XWPharma Ltd.
 XWPharma Ltd. Pharmaceuticals: MajorHealth Technology Xwpharma operates as a biopharmaceutical company. It focuses on eveloping a portfolio of internally discovered product candidates for the treatment of neurological disorders. The company was founded by Jia-Ning Xiang and is headquartered in Wuhan, China. | Director/Board Member | 16.12.2020 |
Ehemalige bekannte Positionen von Michael Morrissey
| Unternehmen | Position | Ende |
|---|---|---|
CERo Therapeutics, Inc.
 CERo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services CERo Therapeutics, Inc. operates as a biopharmaceutical company. It offers cell-based therapies that incorporate multiple forms of tumor clearance into single cells. The company was founded by Daniel Mark Corey and Lawrence Corey and is headquartered in South San Francisco, CA. | Director/Board Member | 01.11.2022 |
| Berlex Biosciences | Corporate Officer/Principal | 01.01.2000 |
| Ciba-Geigy Corp. | Chief Tech/Sci/R&D Officer | 01.01.1991 |
Ausbildung von Michael Morrissey
| Harvard University | Doctorate Degree |
| University of Wisconsin | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
| Ciba-Geigy Corp. | Health Technology |
| Berlex Biosciences | |
XWPharma Ltd.
XWPharma Ltd. Pharmaceuticals: MajorHealth Technology Xwpharma operates as a biopharmaceutical company. It focuses on eveloping a portfolio of internally discovered product candidates for the treatment of neurological disorders. The company was founded by Jia-Ning Xiang and is headquartered in Wuhan, China. | Health Technology |
CERo Therapeutics, Inc.
CERo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services CERo Therapeutics, Inc. operates as a biopharmaceutical company. It offers cell-based therapies that incorporate multiple forms of tumor clearance into single cells. The company was founded by Daniel Mark Corey and Lawrence Corey and is headquartered in South San Francisco, CA. | Commercial Services |
| Vera Therapeutics, Inc. |
